Article
The presence of mutations in epidermal growth factor receptor gene is not a prognostic factor for long-term outcome after surgical resection of non-small-cell lung cancer.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer - 1 Feb 2013
Kim Young Tae, Seong Yong Won, Jung Yoo Jin, Jeon Yoon Kyung, Park In Kyu, Kang Chang Hyun, Kim Joo Hyun
Abstract excerpt
BACKGROUND: The presence of mutation in EGFR gene is known as a predictive marker for the response to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) treatment. However, whether or not these EGFR mutations are prognostic factors for non-small-cell lung cancer (NSCLC) is debatable. METHODS: We retrospectively collected a series of samples from patients whose EGFR mutation status had been...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.